The role of Adenovirus-36 in adults with obesity-induced type 2 diabetes
dc.authorid | 0000-0002-7855-7779 | en_US |
dc.authorscopusid | 57643484200 | en_US |
dc.contributor.author | Tokman, Halit | |
dc.contributor.author | Ergin, Sevgi | |
dc.contributor.author | Sarıbaş, Suat | |
dc.contributor.author | Dinç, Harika Öykü | |
dc.contributor.author | Cengiz, Mahir | |
dc.contributor.author | Yavuzer, Serap | |
dc.contributor.author | Çizmecigil, Utku Yusuf | |
dc.contributor.author | Önder, Nuri T. | |
dc.contributor.author | Yılmaz, Hüseyin | |
dc.contributor.author | Eryiğit, Önder Yüksel | |
dc.contributor.author | Gareayaghi, Nesrin | |
dc.contributor.author | Kocazeybek, Bekir Sami | |
dc.date.accessioned | 2022-12-16T14:32:08Z | |
dc.date.available | 2022-12-16T14:32:08Z | |
dc.date.issued | 2022 | en_US |
dc.department | Meslek Yüksekokulları, Sağlık Hizmetleri Meslek Yüksekokulu, Tıbbi Görüntüleme Teknikleri Programı | en_US |
dc.description.abstract | Background: Obesity may also develop due to a viral infection caused by adenovirus 36. We aimed to detect the presence of neutralizing antibodies against Ad-36 in adult patients who developed type 2 diabetes due to obesity (BMI ≥ 30 kg/m2). Methods: The patient group (PG) was composed of 80 obese people with type 2 diabetes, the patient control group (PCG) was composed of 40 non-obese people with type 2 diabetes, and the healthy control group (HCG) was composed of 40 non-obese people without type 1 or type 2 diabetes in this case-control study. The presence of Ad-36 neutralizing antibodies was studied by serum neutralization assay. Results: A significant difference was found between the PG and HCG in terms of Ad-36 antibody positivity (p < 0.0001) but no significant difference was detected between the PG and the PCG (p > 0.05). BMI, serum leptin, adiponectin, and triglyceride levels were significantly higher in the PG (p < 0.05). Conversely, TNF-α and IL-6 levels were significantly lower in the PG (p < 0.0001). When the two groups were compared, the mean levels of total cholesterol and LDL in the PG were found to be high, although not significant (p > 0.05). In type 2 diabetes patients (n = 120), age, BMI, HDL, LDL, triglyceride, total cholesterol, Ad-36 presence, leptin, adiponectin, TNF-α, and IL-6 parameters were taken as independent variables for logistic regression. While BMIs was found to be significant (odds ration [OR] = 2.358; p = 0.0001, 95% Cl 1.507 - 3.690, Ad-36 presence was found to be a significant (OR = 27.352; p = 0.003, 95% Cl 3.157 - 236.961). Our study showed that BMI and Ad-36 increase type 2 diabetes risk by 2.3 and 27.3-fold in the PG and PCG (type 2 diabetes patients) versus the HCG. There was also a significant difference between PCG and HCG. Conclusions: We suggest that Ad-36 seropositivity is also a risk factor for the development of type 2 diabetes independent of being obese. © 2022 Verlag Klinisches Labor GmbH. All rights reserved. | en_US |
dc.identifier.citation | Tokman, H., Ergin, S., Sarıbaş, S., Dinç, H. Ö., Cengiz, M., Yavuzer, S., Çizmecigil, U. Y., Önder, N. T., Yılmaz, H., Eryiğit, Ö. Y., Gareayaghi, N. & Kocazeybek, B. S. (2022). The role of Adenovirus-36 in adults with obesity-induced type 2 diabetes. Clinical Laboratory, 68(11), 2348-2355. https://dx.doi.org/10.7754/Clin.Lab.2022.220226 | en_US |
dc.identifier.doi | 10.7754/Clin.Lab.2022.220226 | en_US |
dc.identifier.endpage | 2355 | en_US |
dc.identifier.issn | 1433-6510 | |
dc.identifier.issue | 11 | en_US |
dc.identifier.pmid | PMID: 36377995 | en_US |
dc.identifier.scopus | 2-s2.0-85142193136 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 2348 | en_US |
dc.identifier.uri | https://dx.doi.org/10.7754/Clin.Lab.2022.220226 | |
dc.identifier.uri | https://hdl.handle.net/20.500.13055/333 | |
dc.identifier.volume | 68 | en_US |
dc.identifier.wos | WOS:000898559600001 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.indekslendigikaynak.other | SCI-E - Science Citation Index Expanded | en_US |
dc.institutionauthor | Eryiğit, Önder Yüksel | |
dc.language.iso | en | en_US |
dc.publisher | Verlag Klinisches Labor GmbH | en_US |
dc.relation.ispartof | Clinical Laboratory | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Ad-36 | en_US |
dc.subject | Adiponectin | en_US |
dc.subject | Leptin | en_US |
dc.subject | Obesity | en_US |
dc.subject | Type 2 Diabetes | en_US |
dc.title | The role of Adenovirus-36 in adults with obesity-induced type 2 diabetes | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication |
Dosyalar
Orijinal paket
1 - 1 / 1
Kapalı Erişim
- İsim:
- The Role of Adenovirus-36 in Adults with Obesity-Induced Type 2 Diabetes.pdf
- Boyut:
- 250.26 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text
Lisans paketi
1 - 1 / 1
Kapalı Erişim
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama: